VILINBIO
Start SIP
Invest Now
Start SIP in VILINBIO
Performance
- Low
- ₹35
- High
- ₹36
- 52 Week Low
- ₹17
- 52 Week High
- ₹38
- Open Price₹36
- Previous Close₹34
- Volume44,000
- 50 DMA₹28.76
- 100 DMA₹26.90
- 200 DMA₹25.42
Investment Returns
- Over 1 Month + 28.26%
- Over 3 Month + 59.1%
- Over 6 Month + 32.09%
- Over 1 Year + 75.25%
Smart Investing Starts Here Start SIP with Vilin Bio Med for Steady Growth!
Vilin Bio Med Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 220.9
- PEG Ratio
- -
- Market Cap Cr
- 49
- P/B Ratio
- 2.1
- Average True Range
- 1.65
- EPS
- 0.16
- Dividend Yield
- 0
- MACD Signal
- 2.36
- RSI
- 61.88
- MFI
- 79.96
Vilin Bio Med Financials
Vilin Bio Med Technicals
EMA & SMA
Current Price
₹35.40
+
1.5
(4.42%)
- Bearish Moving Average 0
- Bullish Moving Average 16
- 20 Day
- ₹32.06
- 50 Day
- ₹28.76
- 100 Day
- ₹26.90
- 200 Day
- ₹25.42
Resistance and Support
35.45
- R3 35.65
- R2 35.60
- R1 35.50
- S1 35.35
- S2 35.30
- S3 35.20
Vilin Bio Med Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2026-02-16 | Others | (Revised) To consider other business matters - proposed Scheme of Merger/Amalgamation. |
| 2026-01-10 | Fund Raising & Others | To consider other business matters. |
| 2025-11-12 | Quarterly Results | |
| 2025-10-14 | Others | To consider other business matters. |
| 2025-05-17 | Audited Results |
Vilin Bio Med F&O
About Vilin Bio Med
- NSE Symbol
- VILINBIO
- BSE Symbol
- Managing Director
- Mr. Madhusudhan Yadamakanti Reddy
- ISIN
- INE0L4V01013
Similar Stocks to Vilin Bio Med
Vilin Bio Med FAQs
Vilin Bio Med share price is ₹35 As on 20 February, 2026 | 02:08
The Market Cap of Vilin Bio Med is ₹49.4 Cr As on 20 February, 2026 | 02:08
The P/E ratio of Vilin Bio Med is 220.9 As on 20 February, 2026 | 02:08
The PB ratio of Vilin Bio Med is 2.1 As on 20 February, 2026 | 02:08
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.